LONDON, UK, April 8, 2019-- Apposite Capital, the private equity firm with an exclusive focus on healthcare, today announces that it has invested £6m in preferred equity in Mirada Medical, a world leading medical imaging software company. The investment will support Mirada’s development of artificial intelligence (AI) based software for increasing the speed and accuracy of cancer treatment planning applications, while delivering a more personalised level of care to patients. Apposite has invested alongside Mirada’s founding investor, AlbionVC, and other private investors.